Exploration of Cadmium as an Endocrine Disruptor in Prostate Cancer Disparities

This project will further investigate cadmium as an endocrine disruptor of the androgen receptor by capitalizing on a well-defined, ethnically diverse cohort of prostatectomy cases (N=415, 44% AA, diagnosed 1999-2004) that originally participated in the Gene-Environment Interaction in Prostate Cancer (GECAP) (R01 ES11126) study. In prostate tumor and adjacent non-tumor tissue, we will measure cadmium as well as a panel of additional toxic and essential metals that can affect cadmium toxicity, and will also measure the whole-genome transcriptome in tumor tissue.

<< Back to the list of CRN projects

Loading…